Literature DB >> 11521061

Co-operative induction of pro-inflammatory signaling by Toll-like receptors.

A Ozinsky1, K D Smith, D Hume, D M Underhill.   

Abstract

Toll-like receptors (TLRs) mediate detection of a broad range of pathogens and pathogen-derived products including LPS, peptidoglycan, bacterial lipopeptides, and lipoteichoic acid. Recent evidence indicates that the broad specificity of TLRs may be a consequence of the interactions between different TLRs. In this report, we demonstrate that while a constitutively active TLR4 homodimer can induce the production of pro-inflammatory cytokines, homodimers of TLR2 and TLR6 cannot. However, when co-expressed in the same cell, constitutively active TLR2 and TLR6 strongly induce cytokine production, indicating that these TLRs require partners to productively signal. Since TLR4 signals as a homodimer, while TLR2 and TLR6 do not, it is clear that, despite the conservation of their cytoplasmic signaling domains, the mechanisms by which they initiate signaling are different. We have localized the region of TLR4 that mediates its ability to signal as a homodimer to the membrane-proximal half of the cytoplasmic tail of the receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11521061

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  19 in total

1.  Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production.

Authors:  David M Underhill; Eddie Rossnagle; Clifford A Lowell; Randi M Simmons
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

2.  Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

Authors:  Elizabeth Furrie; Sandra Macfarlane; George Thomson; George T Macfarlane
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

Review 3.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance.

Authors:  Manoj Muthukuru; Christopher W Cutler
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 5.  Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.

Authors:  Avi Levin; Oren Shibolet
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

6.  Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways.

Authors:  Chris S Rae; Aimee Geissler; Paul C Adamson; Daniel A Portnoy
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

7.  Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7.

Authors:  Jongdae Lee; Tsung-Hsien Chuang; Vanessa Redecke; Liping She; Paula M Pitha; Dennis A Carson; Eyal Raz; Howard B Cottam
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

8.  Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion.

Authors:  Ashok Kumar; Jing Zhang; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

9.  Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists.

Authors:  Dirk Werling; Jayne C Hope; Chris J Howard; Thomas W Jungi
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

10.  Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection.

Authors:  Sabine Tötemeyer; Neil Foster; Pete Kaiser; Duncan J Maskell; Clare E Bryant
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.